Geode Capital Management »

Gain Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $484k 272k 1.78
2024-06-30 $235k 184k 1.28
2024-03-31 $668k 177k 3.77
2023-09-30 $489k 152k 3.23
2023-06-30 $622k 139k 4.48
2023-03-31 $454k 94k 4.82
2022-12-31 $282k 90k 3.13
2022-09-30 $286k 88k 3.25
2022-06-30 $92k 26k 3.56
2022-03-31 $104k 26k 4.06
2021-12-31 $107k 20k 5.34